The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

NCT05487040 ·Status: TERMINATED ·Phase: PHASE1

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

NCT04475107 ·Status: COMPLETED ·Phase: PHASE2

Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19

NCT04358549 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

NCT05545319 ·Status: WITHDRAWN ·Phase: PHASE2

KAND567 Versus Placebo in Subjects Hospitalized With COVID-19

NCT06012565 ·Status: TERMINATED ·Phase: PHASE2

Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness

NCT05603143 ·Status: TERMINATED ·Phase: PHASE3

A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

NCT05567952 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

NCT05785390 ·Status: TERMINATED ·Phase: PHASE2

A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

NCT05799495 ·Status: COMPLETED ·Phase: PHASE2

Fostamatinib for Hospitalized Adults With COVID-19

NCT04579393 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

NCT05084911 ·Status: COMPLETED ·Phase: PHASE3

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

NCT05195749 ·Status: TERMINATED ·Phase: PHASE2

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

NCT04535167 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19

NCT04582318 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19

NCT05184218 ·Status: TERMINATED ·Phase: PHASE1

Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19

NCT04932915 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

NCT05011513 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19

NCT04545008 ·Status: TERMINATED ·Phase: PHASE1

Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents

NCT05372783 ·Status: WITHDRAWN ·Phase: PHASE2

Niclosamide In Moderate COVID-19

NCT04436458 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of ES16001 in Patients With COVID-19

NCT05525182 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780541 ·Status: TERMINATED ·Phase: PHASE3

Favipiravir Therapy in Adults With Mild COVID-19

NCT04464408 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19

NCT04424901 ·Status: TERMINATED ·Phase: PHASE2

Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19

NCT04724720 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2